Skip to main content

DA Butterfield

First name:
DA
Last name:
Butterfield
Maragos, W., Jakel, R., Chesnut, D., Pocernich, C., Butterfield, D., St Clair, D., & Cass, W. (2000). Methamphetamine toxicity is attenuated in mice that overexpress human manganese superoxide dismutase. Brain Research, 878(1-2), 218-22. https://doi.org/10.1016/s0006-8993(00)02707-4 (Original work published 2000)
Varadarajan, S., Yatin, S., Aksenova, M., & Butterfield, D. (2000). Review: Alzheimer’s amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. Journal of Structural Biology, 130(2-3), 184-208. https://doi.org/10.1006/jsbi.2000.4274
Guo, Z., Ersoz, A., Butterfield, D., & Mattson, M. (2000). Beneficial effects of dietary restriction on cerebral cortical synaptic terminals: preservation of glucose and glutamate transport and mitochondrial function after exposure to amyloid beta-peptide, iron, and 3-nitropropionic acid. Journal of Neurochemistry, 75(1), 314-20. https://doi.org/10.1046/j.1471-4159.2000.0750314.x
Lauderback, C., Breier, A., Hackett, J., Varadarajan, S., Goodlett-Mercer, J., & Butterfield, D. (2000). The pyrrolopyrimidine U101033E is a potent free radical scavenger and prevents Fe(II)-induced lipid peroxidation in synaptosomal membranes. Biochimica et Biophysica Acta, 1501(2-3), 149-61. https://doi.org/10.1016/s0925-4439(00)00015-6 (Original work published 2000)
Aksenov, M., Aksenova, M., Butterfield, D., & Markesbery, W. (2000). Oxidative modification of creatine kinase BB in Alzheimer’s disease brain. Journal of Neurochemistry, 74(6), 2520-7. https://doi.org/10.1046/j.1471-4159.2000.0742520.x
Keller, J., Lauderback, C., Butterfield, D., Kindy, M., Yu, J., & Markesbery, W. (2000). Amyloid beta-peptide effects on synaptosomes from apolipoprotein E-deficient mice. Journal of Neurochemistry, 74(4), 1579-86. https://doi.org/10.1046/j.1471-4159.2000.0741579.x
Pocernich, C., La Fontaine, M., & Butterfield, D. (2000). In-vivo glutathione elevation protects against hydroxyl free radical-induced protein oxidation in rat brain. Neurochemistry International, 36(3), 185-91. https://doi.org/10.1016/s0197-0186(99)00126-6
Butterfield, D., Yatin, S., & Link, C. In vitro and in vivo protein oxidation induced by Alzheimer’s disease amyloid beta-peptide (1-42). Annals of the New York Academy of Sciences, 893, 265-8. https://doi.org/10.1111/j.1749-6632.1999.tb07833.x (Original work published 1999)
Butterfield, D., Koppal, T., Subramaniam, R., & Yatin, S. Vitamin E as an antioxidant/free radical scavenger against amyloid beta-peptide-induced oxidative stress in neocortical synaptosomal membranes and hippocampal neurons in culture: insights into Alzheimer’s disease. Reviews in the Neurosciences, 10(2), 141-9. https://doi.org/10.1515/revneuro.1999.10.2.141 (Original work published 1999)
Yatin, S., Varadarajan, S., Link, C., & Butterfield, D. (1969). In vitro and in vivo oxidative stress associated with Alzheimer’s amyloid beta-peptide (1-42). Neurobiology of Aging, 20(3), 325-30; discussion 339. https://doi.org/10.1016/s0197-4580(99)00056-1 (Original work published 1969)